Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China. - Wikidata - wikimedia - TriplyDB

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.

http://www.wikidata.org/entity/Q37682743

about

Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations.

P2860

Q55483901-09BFFAB6-CE4E-4BFC-9D78-EFDA6E1E295E

P2860

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.

http://www.wikidata.org/entity/Q37682743

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost-effectiveness of nitrendi ...... unity health centers in China.

@en

Cost-effectiveness of nitrendi ...... unity health centers in China.

@nl

type

label

Cost-effectiveness of nitrendi ...... unity health centers in China.

@en

Cost-effectiveness of nitrendi ...... unity health centers in China.

@nl

prefLabel

Cost-effectiveness of nitrendi ...... unity health centers in China.

@en

Cost-effectiveness of nitrendi ...... unity health centers in China.

@nl

P1433

Q37682743-CC3831DB-D08A-43C8-9556-7B6E9C25AE6E

P1476

Q37682743-B32B762D-07CF-4ABA-AB80-C3230C3C5713

P2093

Q37682743-1EC51836-CBBD-44E8-A9F5-C9F42B28A0E7

Q37682743-207041C8-9262-4293-BE77-F28D64103608

Q37682743-222679AA-B4C8-41A4-9DBA-0B50701E7662

Q37682743-71D5F339-662A-4D52-99B3-D06434F4538D

Q37682743-9C3EE002-5039-4F5B-B9C8-3F0BFBFC2D57

Q37682743-A517217A-DFF7-4946-9BE5-CF6D9E2AA8E2

Q37682743-AEA0301E-BD5D-4E27-B486-A1924A194429

Q37682743-B338714B-F1BE-4B27-9FDF-7826F9E69FCD

Q37682743-BFE97D6F-ABBE-4646-9E28-3E6071952586

P2860

Q37682743-02C554E7-2251-44B9-AD96-B565E8D3B391

Q37682743-06489DCE-8659-4273-866B-50D63B52EF70

Q37682743-06C8F62B-9A2C-449E-9EC8-7F8B9542549A

Q37682743-34D4AFE3-AC33-4974-907D-8CDD3F819B9E

Q37682743-40FB59DE-F97A-4365-B738-74EF166E1216

Q37682743-4FE473AD-5E44-44C4-8E71-4F639E5E0A78

Q37682743-5E54E603-E682-431F-ACF0-D6AFE3617140

Q37682743-5E7FCE7A-EFF1-42D0-BFA5-7C5542656C5A

Q37682743-60F9986F-932D-472A-91D0-AD394A413613

Q37682743-B73941EC-9164-4BBD-B07F-666911C99B57

P304

Q37682743-7764F996-CDCF-4618-AB8E-FFC5FA0133C6

P31

Q37682743-1A758521-DE51-4827-97B9-EA9B46D4F7DA

P356

Q37682743-58587B19-82BC-4AEC-82D5-B2F03AF7E9DA

P433

Q37682743-949B62C0-A292-463A-BF66-ED39CBE6218C

P478

Q37682743-1161015C-4D04-4BF4-8F44-2B50FFA3076C

P577

Q37682743-FD76E662-7404-46FF-B186-98EE0AD01030

P698

Q37682743-948890AA-07E3-4AC2-88DA-C3CB7349F099

P921

Q37682743-644E3E32-4F02-49F8-B80A-42B7CCFF4281

P932

Q37682743-9C0290FE-A993-4B7F-A773-CF0780949E61

P356

HJH.0000000000001209

P1433

Journal of Hypertension

P1476

Cost-effectiveness of nitrendi ...... unity health centers in China.

@en

P2093

Guang Hao

http://www.w3.org/2001/XMLSchema#string

Linfeng Zhang

http://www.w3.org/2001/XMLSchema#string

Liyuan Ma

http://www.w3.org/2001/XMLSchema#string

Manlu Zhu

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Xin Zhao

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

Zengwu Wang

http://www.w3.org/2001/XMLSchema#string

Zuo Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

The importance of drug combinations for effective control of hypertension.

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Pharmacoeconomic challenges in disease management of hypertension.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Hypertension: how does management change with aging?

Cost-effectiveness of hypertension treatment: a population-based study.

Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management.

P304

886-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJH.0000000000001209

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27977472

http://www.w3.org/2001/XMLSchema#string

P921

community health

P932

5338889

http://www.w3.org/2001/XMLSchema#string